PAOLETTI, ANNA MARIA
 Distribuzione geografica
Continente #
EU - Europa 244.291
NA - Nord America 17.066
AS - Asia 7.152
SA - Sud America 1.195
AF - Africa 98
Continente sconosciuto - Info sul continente non disponibili 32
OC - Oceania 24
Totale 269.858
Nazione #
IT - Italia 231.650
US - Stati Uniti d'America 16.840
NL - Olanda 6.348
CN - Cina 3.072
SG - Singapore 3.048
UA - Ucraina 2.152
SE - Svezia 1.325
DE - Germania 1.186
BR - Brasile 1.002
FI - Finlandia 533
GB - Regno Unito 469
VN - Vietnam 301
KR - Corea 250
FR - Francia 230
RU - Federazione Russa 165
CA - Canada 154
IN - India 90
HK - Hong Kong 86
AR - Argentina 67
MX - Messico 46
BD - Bangladesh 45
EC - Ecuador 39
PL - Polonia 38
JP - Giappone 37
ZA - Sudafrica 35
EU - Europa 31
AT - Austria 30
TR - Turchia 30
ES - Italia 25
ID - Indonesia 24
BE - Belgio 23
IQ - Iraq 23
PK - Pakistan 20
AU - Australia 18
PY - Paraguay 18
UY - Uruguay 18
RO - Romania 17
CO - Colombia 16
VE - Venezuela 16
MA - Marocco 14
IE - Irlanda 12
LT - Lituania 12
UZ - Uzbekistan 12
CH - Svizzera 11
CL - Cile 11
CZ - Repubblica Ceca 11
PH - Filippine 11
SA - Arabia Saudita 11
IL - Israele 10
PT - Portogallo 10
AE - Emirati Arabi Uniti 9
IR - Iran 9
NP - Nepal 9
EG - Egitto 8
TN - Tunisia 8
AZ - Azerbaigian 7
JO - Giordania 7
KE - Kenya 7
MU - Mauritius 7
MY - Malesia 7
BG - Bulgaria 6
HN - Honduras 6
KZ - Kazakistan 6
NO - Norvegia 6
AL - Albania 5
DK - Danimarca 5
DZ - Algeria 5
LB - Libano 5
MD - Moldavia 5
PE - Perù 5
CR - Costa Rica 4
DO - Repubblica Dominicana 4
NZ - Nuova Zelanda 4
BO - Bolivia 3
ET - Etiopia 3
GT - Guatemala 3
HR - Croazia 3
KG - Kirghizistan 3
LV - Lettonia 3
PS - Palestinian Territory 3
SN - Senegal 3
TH - Thailandia 3
TW - Taiwan 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
GE - Georgia 2
GR - Grecia 2
JM - Giamaica 2
NG - Nigeria 2
PR - Porto Rico 2
RS - Serbia 2
SV - El Salvador 2
AM - Armenia 1
BB - Barbados 1
BM - Bermuda 1
BY - Bielorussia 1
CV - Capo Verde 1
EE - Estonia 1
GA - Gabon 1
Totale 269.843
Città #
Cagliari 225.120
Amsterdam 6.307
Uta 4.957
Fairfield 1.714
Singapore 1.394
Ashburn 1.338
Woodbridge 1.241
Chandler 1.196
Jacksonville 1.152
Boardman 1.047
Dallas 918
Wilmington 887
Ann Arbor 858
Houston 774
Seattle 723
Nyköping 690
Cambridge 568
Beijing 471
Dearborn 387
Nanjing 373
Hefei 335
Boston 278
Los Angeles 256
Seoul 230
Helsinki 201
Santa Clara 186
Buffalo 175
Milan 143
Shenyang 113
San Diego 112
Nanchang 104
Shanghai 100
Toronto 96
Ho Chi Minh City 95
The Dalles 93
Tianjin 89
New York 88
Guangzhou 84
Hong Kong 81
Changsha 78
Hebei 76
Jiaxing 74
Redwood City 74
São Paulo 66
Mountain View 62
Redondo Beach 60
Hanoi 59
Verona 58
Rome 57
Jinan 53
London 53
Norwalk 51
Orange 51
Sassari 45
Washington 45
Munich 39
Chicago 37
Rio de Janeiro 36
Dong Ket 34
Ningbo 33
Auburn Hills 32
Warsaw 30
Zhengzhou 30
Tokyo 29
Brooklyn 28
Nuremberg 28
Columbus 27
Pune 26
Belo Horizonte 25
Atlanta 24
Kunming 22
Frankfurt am Main 21
Johannesburg 21
Redmond 21
Taizhou 21
Curitiba 20
Saint Petersburg 20
Brussels 19
Campinas 18
Council Bluffs 18
Phoenix 18
San Francisco 18
Molise 17
Stockholm 17
Falls Church 16
Montreal 16
Sorocaba 16
Borås 15
Hangzhou 15
San Jose 15
Denver 14
San Mateo 14
Treviso 14
Düsseldorf 13
Guarulhos 13
Haiphong 13
Padova 13
Porto Alegre 13
Augusta 12
Brasília 12
Totale 256.889
Nome #
Long-acting reversible contraception (LARC) with the intrauterine system with levonorgestrel (6 mcg/d): observational study on the acceptability, quality of life, and sexuality in Italian women 4.087
Overview of elagolix for the treatment of endometriosis 3.500
Urinary metabolomics of pregnant women at term: a combined GC/MS and NMR approach 3.361
Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: a prospective one-year evaluation 3.360
Systemic therapy for the treatment of endometrial cancer 3.066
Vaginosi batterica: efficacia di un trattamento locale con un gel vaginale a base di una frazione batterica derivata da Propionibacterium acnes 3.013
The stimulation of the vaginal immune system with short-term administration of a vaginal gel containing fraction of Propionibacterium acnes, hyaluronic acid and polycarbophil is efficacious in vaginal infections dependent on disorders in the vaginal ecosystem 2.957
Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study 2.948
Olfactory performance in relation to sex and hormonal profile in humans 2.891
Repeated two cycles of ulipristal acetate treatment improve the quality of life in premenopausal women with heavy menstrual bleeding dependent on uterine myomas, without impairment of bone health 2.888
Prophylaxis of peripartum haemorrhage using recombinant factor VIIa (rfVIIa) in pregnant women with congenital factor VII deficiency: A case report and literature review 2.720
Body composition and psychological improvement in healthy premenopausal women assuming the oral contraceptive containing micronized estradiol (E2) and nomegestrol acetate (NOMAC) 2.717
Research development of a new GnRH antagonist (Elagolix) for the treatment of endometriosis: a review of the literature 2.666
Studio epidemiologico sull’osteoporosi postmenopausale 2.572
Vilaprisan for treating uterine fibroids 2.536
Dismenorrea e endometriosi: una innovativa alternativa alla terapia farmacologica nel controllo del dolore 2.459
Reduced serum level of THDOC, an anticonvulsant steroid, in women with perimenstrual catamenial epilepsy 2.419
Changes of olfactory sensitivity related to sex and hormonal profile in humans 2.361
Clinical utility of elagolix as an oral treatment for women with uterine fibroids: A short report on the emerging efficacy data 2.328
Placental biomarkers 2.322
Studio osservazionale sul contraccettivo ormonale contenente estradiolo valerato e dienogest in formulazione quadrifasica: accettabilità, effetto favorevole sulla composizione corporea e sullo stato psicologico. 2.209
“CG Fem, PI 82, Vitamina E” per la terapia della menopausa: quali vantaggi per la sintomatologia neurovegetativa peri-post menopausale 2.192
Placental growth factor and preterm delivery 2.141
Pharmacokinetic evaluation of ulipristal acetate for uterine leiomyoma treatment 2.050
Risultati di uno studio pilota sull’efficacia del palmitoiletanolamide + transpolidatina in donne con endometriosi 2.013
Resistenza all’insulina nella PCOS e trattamento con inositolo e acido alfa-lipoico 2.009
Studio osservazionale sul contraccettivo ormonale a base di E2 1,5 mg/NOMAC 2,5 mg in formulazione monofasica 2.002
Maternal perinatal depression, anxiety, fear of birth, and perception of infants’ negative affectivity at three months 1.962
Contraception in chronic kidney disease: a best practice position statement by the kidney and pregnancy group of the Italian Society of Nephrology 1.945
Ultrasonographic soft markers for detection of rectosigmoid deep endometriosis 1.920
STUDIO OSSERVAZIONALE SUL CONTRACCETTIVO ORMONALE A BASE DI ESTRADIOLO (E2) 1.5 MG/NOMEGESTROLO (NOMAC) 2.5 MG IN FORMULAZIONE MONOFASICA: ACCETTABILITA', EFFETTO FAVOREVOLE SULLA COMPOSIZIONE CORPOREA E SUI PARAMETRI ANTROPOMETRICI 1.888
Screening e diagnosi del Diabete Gestazionale in Sardegna: risultati a confronto. 1.880
Modificazioni dell’umore e del comportamento nel puerperio: quali fattori di rischio? 1.871
SARCOPENIA: DIAGNOSI E PROSPETTIVE TERAPEUTICHE 1.871
Il bi-test: solo screening di cromosomopatie fetali? 1.867
Monurelle Biogel® vaginal gel in the treatment of vaginal dryness in postmenopausal women 1.790
Menopause and hormone replacement therapy: the 2017 Recommendations of the Italian Menopause Society 1.790
Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey 1.779
Adherence with ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen supported by the use of a digital tablet dispenser with or without acoustic alarm: an open-label, randomized, multicenter study 1.766
Autoimmunity in gestational diabetes mellitus in Sardinia: a preliminary case-control report 1.742
Psychological effect of the oral contraceptive formulation containing 3 mg of drospirenone plus 30 mu g of ethinyl estradiol 1.735
Fattore di Crescita Placentare (PlGF): correlazioni con la funzione placentare 1.733
Effect of ultramicronized-palmitoylethanolamide and co-micronized palmitoylethanolamide/polydatin on chronic pelvic pain and quality of life in endometriosis patients: An open-label pilot study 1.716
Modificazione dell'umore in gravidanza e nel post-partum: ruolo degli integratori 1.707
Successful laparoscopic management of a giant ovarian cyst 1.707
Diagnosi isteroscopica del tumore endometriale: nostra esperienza 1.680
Changes in GABAA receptor gamma2 subunit gene expression induced by long-term administration of oral contraceptives in rats 1.657
Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group 1.647
Confronto tra diagnosi isteroscopica e istologica delle patologie endometriali maligne, nostra esperienza 1.580
CARATTERISTICHE DELLA "MESTRUAZIONE", DELLA PRESSIONE ARTERIOSA E DEI SINTOMI PSICOLOGICI IN CORSO DI SEI CICLI DI TRATTAMENTO CON IL CONTRACCETTIVO ORMONALE A BASE DI E2 1.5 MG/NOMAC 2.5 MG 1.572
Contraception with estradiol valerate and dienogest: adherence to the method 1.566
Large twisted ovarian fibroma associated with Meigs' syndrome, abdominal pain and severe anemia treated by laparoscopic surgery 1.552
Observational study on the stability of the psychological status during normal pregnancy and increased blood levels of neuroactive steroids with GABA-A receptor agonist activity. 1.532
Gamma-amino-beta-hydroxy butyric acid stimulates prolactin and growth hormone release in normal women 1.522
STUDIO OSSERVAZIONALE SUL CONTRACCETTIVO ORMONALE CONTENENTE ESTRADIOLO VALERATO E DIENOGEST IN FORMULAZIONE QUADRIFASICA: ACCETTABILITA', EFFETTO FAVOREVOLE SULLA COMPOSIZIONE CORPOREA E SULLO STATO PSICOLOGICO 1.519
Osteoporosis's Menopausal Epidemiological Risk Observation (O.M.E.R.O.) study 1.498
Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel 1.472
LE ALTERAZIONI DELLA FASE OVULATORIA 1.447
Non-hormonal strategies for managing menopausal symptoms in cancer survivors: an update 1.432
XO/XY mosaicism with non fluorescent Y chromosome: clinical, cytogenetic and endocrinological studies on a female subject 1.422
Macro-regional variation in attitudes toward and experiences of vulvar and vaginal atrophy among Italian post-menopausal women: a post hoc analysis of REVIVE survey data 1.397
Low androgenization index in elderly women and elderly men with Alzheimer's disease 1.376
Placental growth factor and placental perfusion 1.375
Efficacy of intravenous tramadol treatment for reducing pain during office diagnostic hysteroscopy 1.361
Effects of the dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal women 1.349
INDICAZIONE AL PARTO CESAREO PRESSO LA CLINICA OSTETRICA E GINECOLOGICA DI CAGLIARI: SU QUALI POSSIAMO RIDURRE IL RICORSO AL PARTO CESAREO? 1.346
Relevant changes in nephrogenesis in Down syndrome 1.346
Left : right side ratio of endometriotic implants in the pelvis 1.346
Soy isoflavones, inulin, calcium, and vitamin D3 in post-menopausal hot flushes: an observational study 1.323
The oral contraceptive containing 30 microg of ethinylestradiol plus 3 mg of drospirenone is able to antagonize the increase of extracellular water occurring in healthy young women during the luteal phase of the menstrual cycle: an observational study 1.319
Apparent free cortisol concentration in normal men, non-pregnant, pregnant and postmenopausal women 1.313
The screening of tubal abnormalities in the infertile couple 1.292
Pattern of bone markers during pregnancy and their changes after delivery. 1.289
Evidence that in healthy young women, a six-cycle treatment with oral contraceptive containing 30 mcg of ethinylestradiol plus 2 mg of chlormadinone acetate reduces fat mass 1.276
Multinational, multicentre, randomised, open-label study evaluating the impact of a 91-day extended regimen combined oral contraceptive, compared with two 28-day traditional combined oral contraceptives, on haemostatic parameters in healthy women 1.273
ANALGESIA EPIDURALE E INCIDENZA DI TAGLIO CESAREO. 1.268
Short-term variations in bone remodeling markers of an oral contraception formulation containing 3 mg of drospirenone plus 30 mu g of ethinyl estradiol: observational study in young postadolescent women 1.268
Placental massive perivillous fibrin deposition after a previous uncomplicated term pregnancy: report of two cases. 1.245
EZIOPATOGENESI DEI MIOMI UTERINI 1.234
B-mode and Power Doppler Ultrasound in Adnexsal Masses 1.207
The effect of vulvovaginal atrophy on women’s quality of life from an Italian cohort of the EVES study 1.187
Observational study on the efficacy of tibolone in counteracting early carotid atherosclerotic lesions in postmenopausal women 1.177
Correlazioni tra composizione corporea ed età 1.164
The treatment of polycystic ovary syndrome 1.163
The impact of COVID-19 lockdown on admission to gynecological emergency departments: Results from a multicenter Italian study 1.108
null 1.083
Reflections and recommendations on the COVID-19 pandemic: Should hormone therapy be discontinued? 1.078
The 12-month treatment with the oral contraceptive formulation containing dienogest (DNG) and estradiol valerate (E2V) shows beneficial effects on psychological symptoms: results from a prospective comparative study with a formulation containing ethinyl estradiol (EE) and drospirenone (DRSP) 1.072
Raloxifene does not modify insulin sensitivity and glucose metabolism in postmenopausal women 1.070
La scelta razionale: terapia ormonale a basso dosaggio 1.057
Observational study on the efficacy of the supplementation with a preparation with several minerals amd vitamins in improving mood and behaviour of healty puerperal women 1.053
Contraception during Coronavirus-Covid 19 pandemia. Recommendations of the Board of the Italian Society of Contraception 1.041
CORRELAZIONI PSICO-NEUROENDOCRINE IN GRAVIDANZA. 999
Individualizing surgery for the patient with endometriosis 985
The Role of biochemical screening at 11-14 weeks of gestation as predictor of both trisomy 21 and adverse pregnancy outcomes 966
FATTORI ORMONALI NELLA DEPRESSIONE POSTPARTUM 961
Metabolomic approach to diagnosis of labour 946
Endocrine and metabolic aspects in obese and lean young PCOS 943
Non-enhanced Transvaginal Ultrasonography 937
The antiandrogenic effect of flutamide improves uterine perfusion in women with polycystic ovary syndrome 933
Totale 174.680
Categoria #
all - tutte 379.920
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 379.920


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202124.764 0 0 0 0 0 7.427 6.440 3.458 1.115 2.485 2.495 1.344
2021/202213.719 1.339 1.099 581 1.097 1.273 1.049 1.223 678 1.119 1.172 1.516 1.573
2022/202319.530 2.034 2.185 2.190 1.436 1.536 1.748 773 3.042 1.287 981 1.548 770
2023/202425.933 1.565 1.429 1.192 1.953 2.807 4.246 4.430 1.463 1.198 1.745 2.055 1.850
2024/202541.293 4.382 6.941 5.441 4.813 2.487 4.475 3.433 302 709 6.868 561 881
2025/20267.253 795 924 2.066 1.451 922 1.095 0 0 0 0 0 0
Totale 270.309